|
Volumn 77, Issue 12, 2005, Pages 14-18
|
Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2
a a a a
a
NONE
|
Author keywords
Acute coronary syndrome; Diabetes mellitus type 2; Free radical oxidation; Lisinopril; Proteinuria
|
Indexed keywords
BIOLOGICAL MARKER;
CAPTOPRIL;
CATALASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLUTATHIONE REDUCTASE;
LISINOPRIL;
OXIDOREDUCTASE;
PEROXIDASE;
SUPEROXIDE DISMUTASE;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
FOLLOW UP;
HEART MUSCLE ISCHEMIA;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
NEUTROPHIL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OXIDATIVE STRESS;
PHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SPECTROPHOTOMETRY;
TREATMENT OUTCOME;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BIOLOGICAL MARKERS;
CAPTOPRIL;
CATALASE;
DIABETES MELLITUS, TYPE 2;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
GLUTATHIONE REDUCTASE;
HUMANS;
LISINOPRIL;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
NEUTROPHILS;
OXIDATIVE STRESS;
OXIDOREDUCTASES;
PEROXIDASE;
SEVERITY OF ILLNESS INDEX;
SPECTROPHOTOMETRY;
SUPEROXIDE DISMUTASE;
TREATMENT OUTCOME;
|
EID: 33144461114
PISSN: 00403660
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (31)
|